| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-10 | Vultaggio Vincent PAO and PFO | Sale | -40,224 | -21.54%146,506 | $2.43 | $97,557 | View SEC filing | |
| 2026-02-10 | Bruns Ingmar Chief Medical Officer | Sale | -3,297 | -9.00%33,332 | $2.43 | $7,998 | View SEC filing | |
| 2026-02-10 | EASTLAND JULIA MARIE CEO & President | Sale | -8,755 | -9.96%79,133 | $2.43 | $21,239 | View SEC filing | |
| 2026-02-04 | Vultaggio Vincent PAO and PFO | Sale | -3,096 | -1.63%186,730 | $2.54 | $7,875 | View SEC filing | |
| 2026-01-08 | WALTERS GROUP 10% Owner | Purchase | +6,459,973 | +91.63%13,509,973 | $1.20 | $7,751,968 | View SEC filing | |
| 2025-12-15 | Matrix Capital Management Company, LP 10% Owner | Sale | -7,500,000 | -53.73%6,459,973 | $1.33 | $9,975,000 | View SEC filing | |
| 2025-04-30 | Myers Scott Dunseth Director | Purchase | +21,000 | +8.07%281,192 | $1.40 | $29,373 | View SEC filing | |
| 2025-02-12 | Bruns Ingmar Chief Medical Officer | Purchase | +20,000 | +120.27%36,629 | $2.28 | $45,656 | View SEC filing | |
| 2025-02-05 | Vultaggio Vincent PAO and Interim PFO | Sale | -2,615 | -1.36%189,826 | $1.71 | $4,476 | View SEC filing | |
| 2025-02-05 | Lackner Mark Chief Scientific Officer | Sale | -14,368 | -2.73%512,856 | $1.71 | $24,591 | View SEC filing | |
| 2025-02-05 | Paul Andrea Chief Legal Officer | Sale | -13,230 | -1.22%1,070,784 | $1.71 | $22,643 | View SEC filing | |
| 2025-02-04 | Skvarka Jan Director | Purchase | +60,000 | +67.00%149,551 | $1.72 | $103,446 | View SEC filing | |
| 2025-02-04 | Walker Luke Nathaniel Director | Purchase | +14,200 | +19.59%86,681 | $1.76 | $24,966 | View SEC filing | |
| 2025-02-04 | EASTLAND JULIA MARIE CEO & President | Purchase | +28,500 | +100.00%28,500 | $1.73 | $49,345 | View SEC filing | |
| 2025-01-03 | Lackner Mark Chief Scientific Officer | Sale | -4,411 | -2.25%191,317 | $3.12 | $13,762 | View SEC filing | |
| 2024-10-04 | Vultaggio Vincent Principal Accounting Officer | Sale | -1,603 | -4.52%33,855 | $3.18 | $5,098 | View SEC filing | |
| 2024-05-31 | Gallagher Cam President, Interim CFO | Sale | -9,597 | -1.49%633,680 | $11.98 | $114,972 | View SEC filing | |
| 2024-05-09 | HAUSMAN DIANA Chief Medical Officer | Sale | -3,356 | -0.89%373,876 | $12.62 | $42,353 | View SEC filing | |
| 2024-02-12 | Epperly Melissa B, Chief Financial Officer | Sale | -2,573 | -0.57%451,449 | $11.44 | $29,435 | View SEC filing | |
| 2024-02-12 | Gallagher Cam President | Sale | -1,173 | -0.18%643,277 | $11.44 | $13,419 | View SEC filing | |
| 2024-02-05 | Lackner Mark Chief Scientific Officer | Sale | -1,585 | -0.80%195,728 | $11.54 | $18,291 | View SEC filing | |
| 2024-02-05 | Paul Andrea Chief Legal Officer | Sale | -3,310 | -2.16%149,973 | $11.54 | $38,197 | View SEC filing | |
| 2024-02-05 | Gallagher Cam President | Sale | -11,552 | -1.76%644,450 | $11.54 | $133,310 | View SEC filing | |
| 2024-02-05 | Epperly Melissa B, Chief Financial Officer | Sale | -8,669 | -1.87%454,022 | $11.54 | $100,040 | View SEC filing | |
| 2023-11-13 | Johnson David Michael Director | Purchase | +17,000 | +13.34%144,389 | $9.88 | $167,943 | View SEC filing |
1-25 of 152
